Comparing the IBD patients’ group and taking into account the role of an active inflammatory environment, the microbial composition of the gut did not show significant differences when stratified according to inflammatory indices (fecal calprotectin and C-reactive protein) and the use of specific medications (TNF-alpha inhibitors and anti-integrin drugs). The gene discussed is CRP; the disease is inflammatory bowel disease.